天容 tiān róng | Figure céleste (Nguyen Van Nghi 1971) Le Qi du Ciel arrive au visage (Pan 1993) Réception céleste (Lade 1994) Protège la tête (Laurent 2000) |
---|
Dà róng 大容 (1) | Xi fang zi ming tang jiu jing (Guillaume 1995) |
Items de localisation
Acupuncture | Moxibustion | Source |
---|---|---|
Selon Su wen, appliquer 3 cônes de moxa | Zhen jiu ju ying (Guillaume 1995) | |
Piquer perpendiculairement vers la racine de la langue, à 1-1,5 distance | Cautériser 3 fois, chauffer 5-10 minutes | Roustan 1979 |
Puncture perpendiculaire entre 0,5 et 1 distance de profondeur | Cautérisation avec 3 à 5 cônes de moxa, moxibustion pendant 5 à 10 minutes | Guillaume 1995 |
Piqûre perpendiculaire de 0,5 à 1 cun | Chauffer 10 à 20 mn | Laurent 2000 |
Sensation de puncture
Sécurité
Classe d'usage | - | point secondaire |
---|
Indication | Association | Source |
---|---|---|
Toux avec reflux de Qi vers le haut, dyspnée, expectoration glaireuse, dents serrées | 17IG + 23VC + 42V + 11E + 45V + 18GI | Qian jin (Guillaume 1995) |
Suffocation intermittente | 17IG + 5GI | Zi Shen Jing (Roustan 1979) |
Amygdalite | 17IG + 4GI | Roustan 1979 |
Amygdalite aiguë | 17IG + 11P + 4GI + 3MC | Shanghai zhen jiu xue (Guillaume 1995) |
Pharyngite | 17IG + 4GI + 10V | Roustan 1979 |
Bourdonnements d'oreille avec surdité | 17IG + 2VB + 19IG + 3TR | Qian jin (Guillaume 1995) |
Douleur de l'épaule avec impossibilité de la lever | 17IG + 12IG | Jia yi jing (Guillaume 1995) |
Enflure cervicale, cervicalgie avec impossibilité de regarder en arrière | 17IG + 2IG + 20TR + 4IG + 7IG | Qian jin (Guillaume 1995) |
In the present paper, 8 cases of trigeminal neuralgia were treated with acupuncture of Tianrong point (SI 17) and they were all cured. Tianrong point is located at the superior cervical ganglion of the sympathetic trunk. When needling the point the needle punctures directly on the sympathetic trunk inducing endings of postganglionic fibers to release adrenaline, which exerts regulatory effect on sensory cells in the semilunar ganglion of trigeminal nerves and vessels of the face, so as to attain analgesic effect.
The concentrations of dynorphin (DYN) A1 in CSF and plasma were determined by RIA in migraine patients during attacks (n= 22) and controls (n = 10). The concentration of DYN A1-13 in CSF and plasma in patients with migraine without aura during attacks was significantly decreased compared with their controls (both P<0.01) . The concentrations of CSF DYN A1 –13 in the patients with severe headache was significantly decreased compared with those found, in the patients with moderate headache(P<0.05).These data provide new evidence suggesting the involvement of the endogenous opiate peptides in the pathophysiology of migraine headache and suggest plasma and CSF DYN A1– 13 levels could serve as a biological marker for this condition. After 30 min. of 'I`ianrong acupoint therapy, the concentrations of DYN A1-13 (P<0.05) in plasma of migraine patients were significantly increased compared with before treatment. In the group of headache disappeared,. the concentrations of plasma DYN A,,1-13 were significantly increased (P<0.01) after Tianrong acupoint therapy, but no significant changes were found in effective and ineffective groups. These suggest the analgesic properties of the treatment may be ascribed to an involvement of the endogenous opiates system.
Background and purpose: Vascular and tension-type headache is most commonly encountered, and SI 17 therapy has been tested to treat headache with good results. The efficacy of SI17 therapy for vascular and tension-type headache was compared and the effect of SI17 therapy on pancreatic polypeptide (PP) was studied. Materials and methods: 29 cases of vascular headache (20 cases in acute attack during the trial) and 27 cases of tension-type headache (19 cases in acute attack) were enrolled in the study. Plasma PP level before and 4th day after treatment was measured by radioimmunoassay. Results: SI 17 therapy is better for the treatment of vascular headache. Vascular headache with higher PP level and tension-type headache with normal PP level had good therapeutic results. Conclusion: The clinical efficacy is better for vascular headache with the increase of vagus tension and for tension-type headache with normal vagus tension.
Although Tianrong acupoint (SI 17) is used for migraine headache, its mechanism of action remains obscure. The effects of Tianrong acupoint therapy on neurogenically-mediated plasma protein extravasation (125I-BSA) in rat dura mater induced by electrical stimulation of the right trigeminal ganglion was studied. When the unilateral trigeminal ganglion was stimulated (5 Hz, 1. 2 mA, 5 msec for 5 min), the ratio of stimulated side/unstimulated side (cpm/mg) was 1. 6663 ± 0. 0217. The plasma extravasation was blocked by different kinds of treatment in different degrees. The order of the ratio was as follow : Tianrong acupoint therapy (1. 0917 ± 0. 0266) and Tianrong electrical needle therapy (1. 1281 ± 0. 0227) < Tianrong acupoint injection with normal saline (1. 325 ± 0. 0444) < Quchi acupoint (LI 11) injection with prednisolonum (1. 5284 ± 1. 1624). The results indicated that Tianrong acupoint therapy could inhibit the neurongenic inflammation on the affected side.